Dr. Jan M. Bruder is a postdoc at the Max Planck Institute for Molecular Biology in Münster Germany. His focus is on iPS-based compound screening in human neurodegenerative disease models. He has worked in stem-cell automation and has a background in artificial organs during his work in the ABC (artificial organs, biomaterials, and cells science) program, including cell-material interactions, tissue engineering, and medical devices. Dr. Bruder earned his PhD in Biology at Brown University.